Dashboard
Manage Tickers

HRTX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-buy-on-heron-therapeutics-maintains-5-price-target
Needham Reiterates Buy on Heron Therapeuti...
05/16/2024 09:30:02

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

needham-reiterates-buy-on-heron-therapeutics-maintains-5-price-target
Needham Reiterates Buy on Heron Therapeuti...
05/08/2024 09:35:35

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

heron-therapeutics-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-financial-results-and-reaffirmed-its-fy24-revenue-guidance
Heron Therapeutics shares are trading high...
05/07/2024 12:18:33

heron-therapeutics-reaffirms-fy24-revenue-1380m-1580m-vs-144875m-est
Heron Therapeutics Reaffirms FY24 Revenue ...
05/07/2024 12:03:19

heron-therapeutics-q1-2024-gaap-eps-002-beats-009-estimate-sales-34700m-beat-32975m-estimate
Heron Therapeutics Q1 2024 GAAP EPS $(0.02...
05/07/2024 12:02:10

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(...

why-nucor-shares-are-trading-lower-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Nucor Shares Are Trading Lower? Here A...
04/23/2024 17:53:09

healthstream-reports-upbeat-results-joins-spotify-ryder-system-and-other-big-stocks-moving-higher-on-tuesday
HealthStream Reports Upbeat Results, Joins...
04/23/2024 14:50:19

capital-one-initiates-coverage-on-heron-therapeutics-with-overweight-rating-announces-price-target-of-6
Capital One Initiates Coverage On Heron Th...
04/23/2024 11:14:11

Capital One analyst Tim Chiang initiates coverage on Heron Therapeutics (NASDAQ:HRTX) with a Overweight rating and announces...

needham-reiterates-buy-on-heron-therapeutics-maintains-5-price-target
Needham Reiterates Buy on Heron Therapeuti...
04/11/2024 10:02:04

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

why-is-postoperative-pain-focused-heron-therapeutics-stock-trading-higher-on-wednesday
Why Is Postoperative Pain Focused Heron Th...
03/13/2024 18:41:24

Heron Therapeutics' Q4 2023 results: Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in ac...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 17:31:16

why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Clover Health Investments Shares Are T...
03/13/2024 17:18:56

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

needham-maintains-buy-on-heron-therapeutics-raises-price-target-to-5
Needham Maintains Buy on Heron Therapeutic...
03/13/2024 10:28:03

Needham analyst Serge Belanger maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and raises the price target from $4 to $5.

heron-therapeutics-q4-earnings-insights
Heron Therapeutics: Q4 Earnings Insights
03/12/2024 20:50:06

heron-therapeutics-sees-fy24-revenue-138m-158m
Heron Therapeutics Sees FY24 Revenue $138M...
03/12/2024 20:30:49

Financial Guidance for 2024The Company reaffirms its full-year 2024 guidance for Product Revenues, Net, Adjusted Operating Expe...

heron-therapeutics-q4-2023-adj-eps-007-beats-016-estimate
Heron Therapeutics Q4 2023 Adj EPS $(0.07)...
03/12/2024 20:15:25

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

preview-heron-therapeuticss-earnings
Preview: Heron Therapeutics's Earnings
03/11/2024 15:01:17

why-blackberry-shares-are-trading-lower-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why BlackBerry Shares Are Trading Lower By...
01/24/2024 18:05:27

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private ...

heron-therapeutics-non-opioid-post-operative-pain-drug-approved-for-use-in-additional-orthopedic-soft-tissue-procedures---fda-gives-nod
Heron Therapeutics' Non-Opioid, Post-Opera...
01/24/2024 16:47:59

Zynrelef's expanded FDA approval for soft tissue and orthopedic surgeries, offering superior pain management with lower pai...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION